← Eichor
Condition: Early Lung Cancer Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Early Lung Cancer

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Phase 3 Study of Sunvozertinib Versus Placebo as Adjuvant Therapy in Patients With Early-Stage Non-Small Cell Lung Can
Phase 3 · 49 location(s) · Dizal (Jiangsu) Pharmaceutical Co., Ltd. · NCT07182682Multiomics Tumor Evolution Model of NSCLC
Phase N/A · 1 location(s) · Peking University People's Hospital · NCT05352035Combined Relapse Prediction Model for Resectable Non-Small Cell Patients - a Prospective Clinical Feasibility Trial
NA · 1 location(s) · Chang Gung Memorial Hospital · NCT06262386Neoadjuvant Inhaled Azacytidine With Platinum-Based Chemotherapy and Durvalumab (MEDI4736) - a Combined Epigenetic-Immun
Phase 1/Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT06694454Somatic Health Screening for Adults in Outpatient Psychiatric Care in Denmark (SomaScreen)
NA · 1 location(s) · Amager Hospital · NCT07518446New Method to Differentiate Benign and Malignant Pulmonary Nodules.
Phase N/A · 1 location(s) · China-Japan Friendship Hospital · NCT06056999EXoPERT EMERALD Clinical Study
Phase N/A · 9 location(s) · EXoPERT · NCT07186296Cell Free DNA for the Diagnosis and Treatment in Early NSCLC
Phase N/A · 1 location(s) · Samsung Medical Center · NCT03791034Chronic Toxicities Related to Treatment in Patients With Localized Cancer
NA · 1 location(s) · UNICANCER · NCT01993498Strategy for EArly Recognition of Cancer, COPD & Heart Failure in the Emergency Department
NA · 1 location(s) · NHS Greater Glasgow and Clyde · NCT07391280MONDRIAN: Multi-omics Integrative Modelling for Stereotactic Body Radiotherapy in Early-stage Non-small Cell Lung Cancer
Phase N/A · 2 location(s) · European Institute of Oncology · NCT05974475Early Pulmonary Dysfunction in Childhood Cancer Patients
Phase N/A · 5 location(s) · University Children's Hospital Basel · NCT05427136Early Intervention Strategies for Lung Cancer
NA · 1 location(s) · The First Affiliated Hospital of Guangzhou Medical Universit · NCT06988943FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases
Phase N/A · 1 location(s) · xCures · NCT06539169Neoadjuvant Dupilumab and Cemiplimab in Patients With Early-stage Resectable NSCLC
Phase 1/Phase 2 · 1 location(s) · Icahn School of Medicine at Mount Sinai · NCT06088771Real-world Clinical Outcomes of Patients With Early-stage Lung Cancer After the Surgery
Phase N/A · 1 location(s) · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT06483698IPH5201 and Durvalumab in Patients With Resectable Non-Small Cell Lung Cancer (MATISSE)
Phase 2 · 30 location(s) · Innate Pharma · NCT05742607Integrating Telehealth to Advance Lung Cancer Screening
NA · 1 location(s) · Abramson Cancer Center at Penn Medicine · NCT06638554The Impact of Surgical Technique on Circulating Tumor DNA in Stage I-III Non-Small Cell Lung Cancer
NA · 4 location(s) · Thomas Jefferson University · NCT05502523Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
Phase N/A · 1 location(s) · Washington University School of Medicine · NCT04354064Transbronchial vs Transthoracic Ablation for Early-stage Peripheral Lung Cancer
NA · 1 location(s) · Hangzhou Broncus Medical Co., Ltd. · NCT06052098Electroacupuncture Combined With Immune Checkpoint Inhibitors as Adjuvant Therapy After Surgery for Early-stage Non-smal
Phase 2/Phase 3 · 1 location(s) · Kong Fanming · NCT07034326Early Phase Study of KESONOTIDE™in Participants With Solid Tumours
Phase 1/Phase 2 · 3 location(s) · Filamon LTD · NCT06926075A Machine Learning Approach to Identify Patients With Resected Non-small-cell Lung Cancer With High Risk of Relapse
Phase N/A · 1 location(s) · University Hospital, Toulouse · NCT05732974Prospective Cohort Study Evaluating 18FDG PET-CT for the Early Prediction of the Efficacy of Immunotherapy Associated or
Phase N/A · 1 location(s) · Centre Antoine Lacassagne · NCT06833229Application of Methylation Markers in Early Detection and MRD Monitoring of Lung Cancer
Phase N/A · 1 location(s) · Beijing Haidian Hospital · NCT07257458Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harbor
Phase 3 · 199 location(s) · Boehringer Ingelheim · NCT07195695To Explore the Safety and Efficacy of Hypervision Proton Surgery for Early-stage Non-small Cell Lung Cancer
NA · 1 location(s) · Anhui Provincial Cancer Hospital · NCT07195084Nodule IMmunophenotyping Biomarker for Lung Cancer Early Diagnosis Study
Phase N/A · 9 location(s) · Royal Marsden NHS Foundation Trust · NCT05432739Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
Phase N/A · 36 location(s) · Freenome Holdings Inc. · NCT06122077
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.